Home › Funds › CAPITAL MANAGEMENT CORP /VA › EXEL

CAPITAL MANAGEMENT CORP /VA position in EXEL

EXELIXIS INC · Health Care

CAPITAL MANAGEMENT CORP /VA reported holding 158,325 shares of EXEL (EXELIXIS INC) in its Q3 2026 13F filing — a position valued at US$9.2M, representing 1.39% of its reported portfolio and ranking #31 among its reported holdings. CAPITAL MANAGEMENT CORP /VA has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)158.32K sh
Reported value held$9.25M
Portfolio Weight1.39%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CAPITAL MANAGEMENT CORP /VA's EXEL position evolved

CAPITAL MANAGEMENT CORP /VA first disclosed a stake in EXEL in Q3 2023 at 364,684 shares (US$8.0M). The position peaked in Q4 2024 at 334,045 shares, worth US$11.1M. Across 13 filings, CAPITAL MANAGEMENT CORP /VA increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 158,325 shares valued at US$9.2M — a reduction of -2,995 shares quarter over quarter.. Notable position changes include a 26% trim in Q2 2024 (shares rose 16% over the following quarter), a 29% trim in Q2 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 364.68K $7.97M New
Q4 2023 391.60K $9.39M Add
Q1 2024 459.78K $10.91M Add
Q2 2024 339.92K $7.64M Reduce
Q3 2024 365.27K $9.48M Add
Q4 2024 334.05K $11.12M Reduce
Q1 2025 259.61K $9.58M Reduce
Q2 2025 183.30K $8.08M Reduce
Q3 2025 182.55K $7.54M Hold
Q4 2025 184.97K $8.11M Add
Q1 2026 165.09K $7.08M Reduce
Q2 2026 161.32K $8.78M Reduce
Q3 2026 158.32K $9.25M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EXEL and 13F data

EXEL (EXELIXIS INC) is a Health Care company. 41 other funds we track also report a position in EXEL — the largest reported positions include Renaissance Technologies (US$747.2M), Farallon Capital Management (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EXEL

All EXEL fund holders →

FAQ

How long has CAPITAL MANAGEMENT CORP /VA held EXEL?

CAPITAL MANAGEMENT CORP /VA has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CAPITAL MANAGEMENT CORP /VA's current position in EXEL?

As of Q3 2026, CAPITAL MANAGEMENT CORP /VA holds 158.32K shares of EXEL (EXELIXIS INC), valued at $9.25M, representing 1.39% of its reported portfolio and ranking #31.

Has CAPITAL MANAGEMENT CORP /VA been buying or selling EXEL?

In the latest 13F filing (Q3 2026), CAPITAL MANAGEMENT CORP /VA reduced its position in EXEL. The position peaked in Q4 2024 at 334.05K shares.

Which other funds hold EXEL?

Other major institutional holders of EXEL include Renaissance Technologies, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.